1. Home
  2. LSAK vs TKNO Comparison

LSAK vs TKNO Comparison

Compare LSAK & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • TKNO
  • Stock Information
  • Founded
  • LSAK 1997
  • TKNO 1996
  • Country
  • LSAK South Africa
  • TKNO United States
  • Employees
  • LSAK N/A
  • TKNO N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • TKNO Medicinal Chemicals and Botanical Products
  • Sector
  • LSAK Finance
  • TKNO Health Care
  • Exchange
  • LSAK Nasdaq
  • TKNO Nasdaq
  • Market Cap
  • LSAK 344.5M
  • TKNO 256.9M
  • IPO Year
  • LSAK N/A
  • TKNO 2021
  • Fundamental
  • Price
  • LSAK $4.74
  • TKNO $4.35
  • Analyst Decision
  • LSAK
  • TKNO
  • Analyst Count
  • LSAK 0
  • TKNO 0
  • Target Price
  • LSAK N/A
  • TKNO N/A
  • AVG Volume (30 Days)
  • LSAK 18.6K
  • TKNO 224.0K
  • Earning Date
  • LSAK 09-10-2025
  • TKNO 08-07-2025
  • Dividend Yield
  • LSAK N/A
  • TKNO N/A
  • EPS Growth
  • LSAK N/A
  • TKNO N/A
  • EPS
  • LSAK N/A
  • TKNO N/A
  • Revenue
  • LSAK $574,080,000.00
  • TKNO $38,923,000.00
  • Revenue This Year
  • LSAK $1.06
  • TKNO $9.52
  • Revenue Next Year
  • LSAK $13.32
  • TKNO $15.20
  • P/E Ratio
  • LSAK N/A
  • TKNO N/A
  • Revenue Growth
  • LSAK 4.13
  • TKNO 11.40
  • 52 Week Low
  • LSAK $3.39
  • TKNO $4.00
  • 52 Week High
  • LSAK $5.60
  • TKNO $10.37
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 51.59
  • TKNO 43.35
  • Support Level
  • LSAK $4.60
  • TKNO $4.22
  • Resistance Level
  • LSAK $4.76
  • TKNO $4.94
  • Average True Range (ATR)
  • LSAK 0.11
  • TKNO 0.29
  • MACD
  • LSAK -0.01
  • TKNO -0.00
  • Stochastic Oscillator
  • LSAK 36.73
  • TKNO 16.75

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: